Dr Rodger McMillan
Rodger McMillan trained in pharmacology at Glasgow and obtained his PhD in Cambridge before moving to the United States where he was an Arthritis Foundation post-doctoral fellow at Dartmouth College. During this time he developed a strong research interest in the pharmacological regulation of leukocytes and inflammation, an area he pursued when he joined ICI pharmaceuticals in 1980.
Rodger spent over 30 years in the pharmaceutical industry with ICI, Zeneca and AstraZeneca and gained experience in several therapeutic areas including rheumatology, respiratory, cardiovascular and neurosciences. From 1999 he was senior vice president for Respiratory and Inflammation at AstraZeneca and was responsible for over 50 projects entering clinical development. He retired in 2012 from AstraZeneca where he was a senior R&D executive.
After leaving AstraZeneca, Rodger has operated as an independent consultant in life sciences and healthcare working with academic groups, SMEs and research charities.
Ian was treasurer of the Arthritis Care Northern Ireland Committee.
He was educated at Manchester University, graduating in Electrical Engineering and later gaining a post-graduate Diploma in Management Science.
He worked in the Northern Ireland Civil Service for more than 30 years, then spent nine years as Chief Executive of the Action Mental Health charity. Ian retired in 2010 and lives in Northern Ireland with his family.
Ian has many years of voluntary experience, including chairing the boards of governors at two primary schools over a 30-year period. He was a director of UK Skills for 15 years, chairing its audit and risk committee during. He also spent 13 years at Belfast Metropolitan College, as vice chair then chair of its Governing Body.
Professor Jon Cohen
Professor Jon Cohen is Emeritus Professor at Brighton and Sussex Medical School, Universities of Brighton and Sussex, and Visiting Professor in Infectious Diseases at Imperial College of Science, Technology and Medicine, London.
He obtained a Wellcome fellowship to train in infectious diseases at Duke University in North Carolina, and then established a department of infectious diseases at Hammersmith Hospital and the Royal Postgraduate Medical School in London.
In 2002 Professor Cohen was appointed to be the founding dean of the new medical school that had been established in Brighton, stepping down from that role in 2013. He's currently president of the International Society of Infectious Diseases, a member of the Scientific Advisory Board of the Lister Foundation and a non-executive director of Kings NHS Foundation Trust.
Juliette Scott leads Customer Insight and Analytics across Europe for eBay. She has a successful track record as a business leader in the corporate world and through running her own business.
Juliette’s commercial experience has been built in the media, fashion and car leasing worlds. More recently, she has helped businesses drive better performance through understanding customers. Juliette worked for dunnhumby for seven years before moving to ebay in 2013.
She was announced as a Trustee of Arthritis Research UK in May 2014.
Karin Hogsander is an independent senior advisor and non-executive in healthcare and life sciences, and currently the interim managing director of Health Navigator UK.
She was formerly the head of M&A/acting transition director for Bupa Global North America, responsible for strategy and international expansion, mostly in Europe, Singapore and the US.
Karin was the executive partner for business and commercial development of Circle, one of the UK’s largest private healthcare providers. At Circle, Karin led the successful bid for the Hinchingbrooke Health Care Trust, the first NHS trust to be managed by a private operator.
Earlier positions include director of business development at UBM Medica. Karin was also a long-standing member of the healthcare practice of the Boston Consulting Group and she led healthcare projects as an associate with JP Morgan’s investment banking practice.
Karin was educated at the Stockholm School of Economics and the Booth School of Business, University of Chicago. She was announced as a Trustee of Arthritis Research UK in May 2014.
Phil Gray is chair and trustee of ARMA (Arthritis and Musculoskeletal Alliance). He was the chief executive of the Chartered Society of Physiotherapy (CSP), where he played a key leadership role in promoting the profession, raising its profile and influencing government, commissioners, civil servants, senior managers, patient and partner organisations. He’s an honorary fellow of the CSP.
Professor David Isenberg
Professor Isenberg is the Academic Director of Rheumatology at University College London and has held the chair established by Arthritis Research UK at University College London since 1996, and is a leading figure in British academic rheumatology. He's the past president of the British Society for Rheumatology (2004-2006).
Professor Isenberg has run the lupus clinic at University College Hospital for the past 25 years and has been elected to fellowships of both the Royal College of Physicians and the Academy of Medical Sciences.
Professor Martijn Steultjens
Martijn has been a Trustee of the Arthritis Care Board since 2016.
Martijn is from the Netherlands, where he studied to become a human movement scientist specialising in biomechanics and epidemiology. He later completed a PhD on causes of pain and disability in osteoarthritis patients. He is currently Chair in Musculoskeletal Health at Glasgow Caledonian University, leading research for long-term conditions, including musculoskeletal health.
He is closely involved with the Scottish Parliament’s cross-party work to improve health care for patients with chronic joint pain in Scotland. Martijn has also authored many scientific publications about rheumatology, orthopaedics, and rehabilitation medicine.
Outside of work, he enjoys cycling, camping trips with his family, and is a youth rugby coach.
Sarah (Sallie) Lamb
Sallie Lamb is the Mireille Gillings Professor of Health Innovation at the University of Exeter, with an established programme of internationally recognised research in arthritis and skeletal problems and a longstanding commitment to high-quality clinical trials to improve patient outcomes and efficiency of health services.
She's a chartered physiotherapist and has worked in research and clinical practice in the NHS over many years.
Sallie has worked extensively with health research funders, particularly in the public (governmental) sector. She was previously chair of the National Institute of Health Research Health Technology Assessment funding board and has had a variety of roles around the allocation, award, distribution, governance and monitoring of medical research funds.
Andrew is ACA qualified and also holds a PhD in Biochemistry from Royal Holloway, London University. He is a highly accomplished senior executive with over 11 years’ experience working at board level in a variety of challenging, multi-national roles including Finance, IT, Business Strategy, Business Development and Audit and Risk management.
Andrew has been Group Financial Controller at Johnson Matthey since 2017, reporting to the CFO. Previously he was the CFO for GSK’s supply chain, reporting to the Group CFO and President of Global Manufacturing & Supply, responsible for a £6bn cost base, supporting £24bn sales.
Andrew has worked with a number of charities over the last 5 years, firstly embedding a development programme at GSK with Arrival Education to work with students from challenging backgrounds looking to achieve their true potential. He also held a non-executive position with the Business Disability Forum and has been a co-opted member of Versus Arthritis’ Finance Committee since 2015, becoming Trustee of the Board and Chair of the Finance Committee in March 2019.